Zusammenfassung
Genetische Defekte können sich sehr unterschiedlich auswirken: von belanglos bis hin zu lebensbedrohlich. Genetische Störungen wie Diabetes oder Muskeldystrophie werden in der Regel als Krankheiten erachtet, andere hingegen, wie Gaumenspalten und Farbenblindheit als Erbdefekte. Bei allen handelt es sich jedoch um das Ergebnis von Mutationen des genetischen Materials, der DNA. Manche Krankheiten werden direkt durch Mutationen hervorgerufen, aber auch die Anfälligkeit für Infektionskrankheiten und andere schädliche Umwelteinflüsse wie Strahlung wird durch die Gene beeinflusst.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Weiterführende Literatur
Antonarakis SE, Epstein CJ (2006) The challenge of Down syndrome. Trends Mol Med 12: 473–479
Butland SL, Devon RS, Huang Y, Mead CL, Meynert AM, Neal SJ, Lee SS, Wilkinson A, Yang GS, Yuen MM, Hayden MR, Holt RA, Leavitt BR, Ouellette BF (2007) CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 8: 126
Edwards CA, Ferguson-Smith AC (2007) Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol 19: 281–289
Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433–440
Gadsby DC, Vergani P, Csanády L (2006) The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440: 477–483
Green NS, Dolan SM, Murray TH (2006) Newborn screening: Complexities in universal genetic testing. Am J Public Health 96: 1955–1959
Hore TA, Rapkins RW, Graves JA (2007) Construction and evolution of imprinted loci in mammals. Trends Genet 23: 440–448
Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8: 253–262
Krokan HE, Kavli B, Slupphaug G (2004) Novel aspects of macromolecular repair and relationship to human disease. J Mol Med 82: 280–297
Li SH, Li XJ (2004) Huntingtin-protein interactions and the pathogenesis of Huntington’s disease. Trends Genet 20: 146–154
Nithianantharajah J, Hannan AJ (2007) Dynamic mutations as digital genetic modulators of brain development function and dysfunction. Bioessays 29: 525–535
Ollero M, Brouillard F, Edelman A (2006) Cystic fibrosis enters the proteomics scene: New answers to old questions. Proteomics 6: 4084–4099
Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30: 575–621
Paul S (2007) Polyglutamine-mediated neurodegeneration: Use of chaperones as prevention strategy. Biochemistry (Moscow) 72: 359–366
Ranum LP, Cooper TA (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29: 259–277
Ranum LP, Day JW (2004) Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 74: 793–804
Reik W (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447: 425–432
Sangiuolo F, D’Apice MR, Gambardella S, Di Daniele N, Novelli G (2004) Toward the pharmacogenomics of cystic fibrosis — an update. Pharmacogenomics 5: 861–878
Taylor RW (2005) Gene therapy for the treatment of mitochondrial DNA disorders. Expert Opin Biol Ther 5: 183–194
Rights and permissions
Copyright information
© 2009 Spektrum Akademischer Verlag Heidelberg
About this chapter
Cite this chapter
Clark, D.P., Pazdernik, N.J. (2009). Genetische Störungen. In: Molekulare Biotechnologie. Spektrum Akademischer Verlag, Heidelberg. https://doi.org/10.1007/978-3-8274-2189-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-8274-2189-0_16
Published:
Publisher Name: Spektrum Akademischer Verlag, Heidelberg
Print ISBN: 978-3-8274-2128-9
Online ISBN: 978-3-8274-2189-0
eBook Packages: Life Science and Basic Disciplines (German Language)